Advertisement
Screener

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) EBITDA

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$20.90M*; Operating income -$21.10M; Depreciation and amortization $197.00K*.
  • 2026-03-31: Basis Reported; EBITDA $30.22M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$23.99M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$40.01M*; Operating income -$40.24M; Depreciation and amortization $229.00K*.

Complete source-backed ebitda history.

Available history
2011-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$20.90M*-$21.10M$197.00K*$1.01M-2069.70%*(m)-$25.05M*(m)$8.80M(m)$2.00K
2026-03-31Reported$30.22M(m)(m)(m)59.16%(m)$28.88M(m)$12.63M(m)$1.00K
2025-12-31Reported-$23.99M(m)(m)(m)-114214.29%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$40.01M*-$40.24M$229.00K*$2.42M-1656.77%*(m)-$40.56M*(m)$28.94M(m)-$371.00K
2025-06-30Reported-$84.39M*-$84.62M$225.00K*$4.42M-1909.30%*(m)-$46.34M*(m)$40.52M(m)$44.80M
2025-03-31Reported-$65.36M(m)(m)(m)-2311.10%(m)-$53.36M(m)$50.81M(m)-$1.18M
2024-12-31Reported-$64.68M(m)(m)(m)-3046.44%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$66.29M*-$66.51M$226.00K*$970.00K-6833.71%*(m)-$45.19M*(m)$50.72M(m)-$835.00K
2024-06-30Reported$58.61M*$58.38M$231.00K*$132.01M44.40%*(m)$15.96M*(m)$57.51M(m)-$2.04M
2024-03-31Reported-$81.31M(m)(m)(m)-162626.00%(m)-$73.05M(m)$64.11M(m)-$2.20M
2023-12-31Reported-$78.24M(m)(m)(m)-24759.18%(m)(m)(m)(m)(m)(m)
2023-09-30Reported$10.54M*$10.31M$229.00K*$84.87M12.42%*(m)$9.52M*(m)$57.91M(m)-$3.09M
2023-06-30Reported-$66.28M*-$66.50M$222.00K*$4.02M-1649.22%*(m)-$44.93M*(m)$56.01M(m)-$4.31M
2023-03-31Reported-$56.12M(m)(m)(m)-2587.55%(m)-$47.46M(m)$44.76M(m)-$2.91M
2022-12-31Reported$124,000.00(m)(m)(m)0.25%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$50.15M*-$50.33M$182.00K*$1.52M-3305.87%*(m)-$31.17M*(m)$39.86M(m)-$2.65M
2022-06-30Reported-$43.02M*-$43.21M$184.00K*$1.31M-3279.34%*(m)-$35.26M*(m)$31.57M(m)-$1.33M
2022-03-31Reported-$37.76M(m)(m)(m)-3275.11%(m)-$37.41M(m)$27.26M(m)-$1.67M
2021-12-31Reported-$32.85M(m)(m)(m)-2803.07%(m)(m)(m)(m)(m)(m)
2021-09-30Reported$109.51M*$109.23M$280.00K*$139.17M78.68%*(m)$112.11M*(m)$17.99M(m)-$51.00K
2021-06-30Reported$28.24M*$27.95M$291.00K*$60.07M47.01%*(m)$36.62M*(m)$21.09M(m)$254.00K
2021-03-31Reported-$31.81M(m)(m)(m)-19878.13%(m)-$33.67M(m)$21.14M(m)$4.66M
2020-12-31Reported-$29.95M(m)(m)(m)-8318.33%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$30.46M*-$30.85M$387.00K*$157.00K-19400.64%*(m)-$19.40M*(m)$21.61M(m)-$215.00K
2020-06-30Reported-$26.35M*-$26.73M$381.00K*$195.00K-13513.33%*(m)-$18.70M*(m)$17.27M(m)-$255.00K
2020-03-31Reported-$24.46M(m)(m)(m)-17350.35%(m)-$23.17M(m)$15.25M(m)-$166.00K
2019-12-31Reported-$22.87M(m)(m)(m)-8935.16%(m)(m)(m)(m)(m)(m)
2019-09-30Reported-$20.58M*-$20.97M$392.00K*$205.00K-10039.02%*(m)-$8.94M*(m)$12.49M(m)$468.00K
2019-06-30Reported-$18.11M*-$18.50M$387.00K*$167.00K-10844.31%*(m)-$12.10M*(m)$9.58M(m)-$156.00K
2019-03-31Reported-$22.57M(m)(m)(m)-12133.87%(m)-$17.43M(m)$13.30M(m)$198.00K
2018-12-31Reported-$21.93M(m)(m)(m)-11303.61%(m)(m)(m)(m)(m)(m)
2018-09-30Reported-$23.53M*-$24.32M$794.00K*(m)(m)(m)-$33.57M*(m)$18.52M(m)$962.00K
2018-06-30Reported-$62.27M*-$63.07M$799.00K*(m)(m)(m)$58.13M*(m)$31.45M(m)-$1.95M
2018-03-31Reported-$47.91M(m)(m)(m)-21106.17%(m)-$31.58M(m)$34.71M(m)-$37.00K
2017-12-31Reported-$46.54M(m)(m)(m)-20320.96%(m)(m)(m)(m)(m)(m)
2017-09-30Reported-$52.77M*-$53.53M$767.00K*(m)(m)(m)-$17.74M*(m)$41.31M(m)-$1.71M
2017-06-30Reported-$17.37M*-$18.13M$759.00K*(m)(m)(m)-$36.08M*(m)$34.03M(m)-$1.29M
2017-03-31Reported-$35.51M(m)(m)(m)-13711.20%(m)-$37.84M(m)$25.70M(m)-$1.66M
2016-12-31Reported-$48.36M(m)(m)(m)-28280.12%(m)(m)(m)(m)(m)(m)
2016-09-30Reported-$41.86M*-$42.69M$830.00K*(m)(m)(m)-$30.06M*(m)$26.84M(m)$421.00K
2016-06-30Reported-$39.73M*-$40.16M$428.00K*(m)(m)(m)-$27.33M*(m)$32.36M(m)$189.00K
2016-03-31Reported-$27.16M(m)(m)(m)-10248.68%(m)-$25.06M(m)$20.49M(m)$181.00K
2015-12-31Reported-$23.99M(m)(m)(m)-7815.64%(m)(m)(m)(m)(m)(m)
2015-09-30Reported-$22.46M*-$22.66M$200.00K*(m)(m)(m)-$16.91M*(m)$17.18M(m)$238.00K
2015-06-30Reported-$17.84M*-$18.04M$195.00K*(m)(m)(m)-$11.14M*(m)$12.79M(m)$195.00K
2015-03-31Reported-$14.84M(m)(m)(m)-2501.85%(m)-$14.72M(m)$10.57M(m)$266.00K
2014-12-31Reported-$12.91M(m)(m)(m)-641.38%(m)(m)(m)(m)(m)(m)
2014-09-30Reported-$12.93M(m)(m)(m)-870.26%(m)-$12.27M*(m)$10.39M(m)$241.00K
2014-06-30Reported$1.77M(m)(m)(m)11.70%(m)$6.21M*(m)$8.62M(m)$296.00K
2014-03-31Reported$18.19M(m)(m)(m)56.44%(m)$17.89M(m)$9.34M(m)$151.00K
2013-12-31Reported-$10.47M(m)(m)(m)-6269.46%(m)(m)(m)(m)(m)(m)
2013-09-30Reported-$9.47M(m)(m)(m)-5535.67%(m)-$10.30M*(m)$6.35M(m)$137.00K
2013-06-30Reported-$10.99M(m)(m)(m)-6582.04%(m)-$6.86M*(m)$8.15M(m)$124.00K
2013-03-31Reported-$8.83M(m)(m)(m)-5163.74%$110.00K-$5.10M(m)$5.96M(m)$6.00K
2012-12-31Reported-$12.06M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-09-30Reported-$8.59M*-$8.67M$78.00K*(m)(m)(m)-$7.45M*(m)$7.53M(m)$0.00
2012-06-30Reported-$9.60M*-$9.71M$115.00K*(m)(m)(m)-$10.36M*(m)$8.02M(m)(m)
2012-03-31Reported-$10.7M(m)(m)(m)(m)$137.00K-$8.62M(m)$8.76M(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$213.75M(m)(m)(m)-2207.20%(m)-$163.58M(m)$134.85M(m)$43.26M
2024-12-31Reported-$153.67M(m)(m)(m)-113.70%(m)-$150.05M(m)$222.52M(m)-$6.62M
2023-12-31Reported-$190.11M(m)(m)(m)-208.06%(m)-$133.91M(m)$220.57M(m)-$13.45M
2022-12-31Reported-$130.81M(m)(m)(m)-242.67%(m)-$108.82M(m)$135.56M(m)-$8.66M
2021-12-31Reported$73.09M(m)(m)(m)36.44%(m)$92.61M(m)$82.28M(m)$4.95M
2020-12-31Reported-$111.22M(m)(m)(m)-13038.69%(m)-$80.36M(m)$74.88M(m)-$283.00K
2019-12-31Reported-$84.13M(m)(m)(m)-10335.75%(m)-$52.97M(m)$50.84M(m)$379.00K
2018-12-31Reported-$155.64M(m)(m)(m)-16297.28%(m)-$28.28M(m)$101.18M(m)-$470.00K
2017-12-31Reported-$152.19M(m)(m)(m)-553.03%(m)-$131.18M(m)$134.55M(m)-$4.37M
2016-12-31Reported-$157.11M(m)(m)(m)-14891.75%(m)-$116.25M(m)$119.53M(m)$1.14M
2015-12-31Reported-$79.13M(m)(m)(m)-4924.14%(m)-$58.60M(m)$58.44M(m)$701.00K
2014-12-31Reported-$5.91M(m)(m)(m)-11.61%(m)-$683.00K(m)$38.45M(m)$811.00K
2013-12-31Reported-$39.77M(m)(m)(m)-5882.69%(m)-$32.10M(m)$26.05M(m)$415.00K
2012-12-31Reported-$40.94M(m)(m)(m)-1540.33%(m)-$42.07M(m)$34.14M(m)$6.00K
2011-12-31Reported-$28.85M(m)(m)(m)(m)(m)-$19.70M(m)$24.17M(m)$426.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10